| Literature DB >> 29649120 |
Eliza L Gordon1, Aviva H Ariel-Donges2, Viviana Bauman3, Lisa J Merlo4.
Abstract
The diagnostic construct of "food addiction" is a highly controversial subject. The current systematic review is the first to evaluate empirical studies examining the construct of "food addiction" in humans and animals. Studies were included if they were quantitative, peer-reviewed, and in the English language. The 52 identified studies (35 articles) were qualitatively assessed to determine the extent to which their findings indicated the following addiction characteristics in relation to food: brain reward dysfunction, preoccupation, risky use, impaired control, tolerance/withdrawal, social impairment, chronicity, and relapse. Each pre-defined criterion was supported by at least one study. Brain reward dysfunction and impaired control were supported by the largest number of studies (n = 21 and n = 12, respectively); whereas risky use was supported by the fewest (n = 1). Overall, findings support food addiction as a unique construct consistent with criteria for other substance use disorder diagnoses. The evidence further suggests that certain foods, particularly processed foods with added sweeteners and fats, demonstrate the greatest addictive potential. Though both behavioral and substance-related factors are implicated in the addictive process, symptoms appear to better fit criteria for substance use disorder than behavioral addiction. Future research should explore social/role impairment, preoccupation, and risky use associated with food addiction and evaluate potential interventions for prevention and treatment.Entities:
Keywords: eating behavior; food addiction; process addiction; systematic review
Mesh:
Year: 2018 PMID: 29649120 PMCID: PMC5946262 DOI: 10.3390/nu10040477
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Definitions of addiction.
| Source | Definition |
|---|---|
| English Oxford Dictionary [ | “Physically and mentally dependent on a particular substance.” |
| American Psychological Association [ | “A chronic disorder with biological, psychological, social and environmental factors influencing its development and maintenance. Genes affect the degree of reward that individuals experience when initially using a substance (e.g., drugs) or engaging in certain behaviors (e.g., gambling), as well as the way the body processes alcohol or other drugs. Heightened desire to re-experience use of the substance or behavior, potentially influenced by psychological (e.g., stress, history of trauma), social (e.g., family or friends’ use of a substance), and environmental factors (e.g., accessibility of a substance, low cost) can lead to regular use/exposure, with chronic use/exposure leading to brain changes.” |
| American Society of Addiction Medicine [ | “A primary, chronic disease of brain reward, motivation, memory and related circuitry. Dysfunction in these circuits leads to characteristic biological, psychological, social and spiritual manifestations. This is reflected in an individual pathologically pursuing reward and/or relief by substance use and other behaviors. Addiction is characterized by inability to consistently abstain, impairment in behavioral control, craving, diminished recognition of significant problems with one’s behaviors and interpersonal relationships, and a dysfunctional emotional response. Like other chronic diseases, addiction often involves cycles of relapse and remission. Without treatment or engagement in recovery activities, addiction is progressive and can result in disability or premature death.” |
| American Psychiatric Association [ | “A complex condition, a brain disease that is manifested by compulsive substance use despite harmful consequence. People with addiction (severe substance use disorder) have an intense focus on using a certain substance(s), such as alcohol or drugs, to the point that it takes over their life. They keep using alcohol or a drug even when they know it will causes problems. Yet a number of effective treatments are available and people can recover from addiction and lead normal, productive lives.” |
Substance Use Disorder criteria, adapted from the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) [1].
|
Consuming a substance in greater amounts or over longer periods of time than intended. Having a persistent desire or unsuccessfully attempting to decrease or limit substance use. Spending a significant amount of time acquiring, using, or recovering from a substance. Craving the substance or having a strong urge to use it. |
|
Being unable to fulfill obligations at work, school, or home due to use of a substance. Continually using a substance despite its effects causing or exacerbating persistent or recurrent social or interpersonal problems. Giving up or reducing social, occupational, or recreational activities due to substance use. |
|
Continually using a substance in situations in which it is physically dangerous (e.g., driving under the influence of a substance). Continually using a substance despite physical or psychological problems that are caused or made worse by the substance use. |
|
Needing a substantially higher dose of the substance to achieve the desired effect; or experiencing a substantially reduced effect of the substance when the usual dose is consumed (i.e., tolerance). Experiencing negative physical and psychological symptoms when the substance is not consumed at the typical dose or frequency (i.e., withdrawal). |
Note. To meet DSM-5 criteria for a substance use disorder, clinical distress or impairment must be evidenced by two or more of the above symptoms within a 12-month period. Severity is classified as mild (2–3 symptoms), moderate (4–5 symptoms), or severe (≥6 symptoms).
Figure 1Study selection flow diagram, presented according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [35,36].
Characteristics of included studies.
| First Author (Year) | Study Type | Sample Characteristics | Independent Variable(s) | Outcome(s) | |
|---|---|---|---|---|---|
| Adams (2015) [ | Animal | Male Long-Evans rats | 16/8 | Restricted, equicaloric high-fat/low-sugar vs. low-fat/high-sugar diets | Impulsivity and attention, measured by the five-choice serial reaction time task; dopamine signaling in the dorsal and ventral striatum; insulin and leptin levels in the plasma |
| Burmeister (2013) [ | Cross-sectional | Adults with obesity in a behavioral weight-loss program | 57/0 | Food addiction symptoms (YFAS continuous) | 7-week weight change; measures of psychological distress, disordered eating, weight bias, and weight-focused attitudes |
| Cambridge (2013) [ | Double-blind, placebo-controlled parallel group study | Adults with obesity and moderate binge eating | 16/14 | Mu-opioid receptor antagonist (GSK1521498) or placebo | Brain responses to food images (FMRI and behavioral measures); motivation to expend energy to view comparable images |
| Colantuoni (2001) [ | Animal | Female Sprague-Dawley rats | 10/5 | “Intermittent excessive sugar intake” (25% glucose solution with chow for 12 h followed by 12 h of food deprivation each day) | Receptor binding (e.g., dopamine, opioid) |
| Cornelis (2016) [ | Genome-wide association study | Women of European ancestry participating in the Nurses’ Health Study | 9314/0 | Food addiction (mYFAS) | Enrichment of SNPs, genes, and pathways implicated in drug addiction |
| Daubenmier (2014) [ | Cross-sectional | Women in a waitlist control for a randomized controlled trial of a mindfulness intervention for stress eating | 16/17 | Naltrexone-induced nausea and cortisol levels (measure of central opioidergic activity) | Indices of hedonic-related eating behaviors (binge, emotional, external, or restrained eating); intake of sweets/desserts, carbohydrates; interoceptive awareness; adiposity; weight change |
| Davis (2011) [ | Cross-sectional | Adults with obesity | 18/54 | Food addiction (YFAS dichotomous) | Clinical co-morbidities (e.g., binge eating disorder, attention deficit hyperactivity disorder), psychological risk factors (e.g., impulsivity), and abnormal motivation for the addictive substance |
| Davis (2013) [ | Case-control | Adults recruited for study on overeating/overweight | 21/99 | Composite index of elevated dopamine signaling (a multi-locus genetic profile score) | Food addiction (YFAS dichotomous); eating-related sub-phenotypes of food addiction (e.g., binging) |
| Davis (2014) [ | Three-way mixed model, double-blind cross-over | Adults, predominately overweight/obese | 23/113 | Food addiction (YFAS dichotomous); psychomotor stimulant (methylphenidate) vs. placebo | Appetite, cravings, and consumption of favorite snack |
| De Ridder (2016) [ | Cross-sectional | Adults | 38/34 | Weight category (normal vs. obese BMI); food addiction (YFAS continuous) | EEG; hunger; behavioral inhibition; eating style; binge eating; food awareness |
| Duarte (2014) [ | Animal | Marmoset monkeys | 6/8 | 15 min exposure to 50 g chocolate | Conditioned-place-preference |
| Feldstein Ewing (2017) [ | Cross-sectional | Youth, overweight/obese | 24/0 | Beverage type (sweetened soft drink vs. water); food addiction (YFAS continuous); BMI; insulin resistance | Urge to eat; FMRI response patterns (BOLD activation) |
| Fowler (2014) [ | Secondary data analyses | Adults, 2.7 years post-bariatric surgery | 154/0 | Pre-surgical problems with high-sugar/low-fat foods and foods with a high glycemic index | Risk for new onset substance use disorder post-surgery |
| Franken (2016) [ | Cross-sectional | Students recruited for larger YFAS study | 34/34 | Food addiction (YFAS continuous) | Cognitive control (error monitoring) via Eriksen flanker task and EEG (ERN, Pe) |
| Furlong (2014) [ | Animal | Male Long-Evans rats | 24/12 | Continuous vs. restricted access to sweetened condensed milk (3:1 ratio of Nestle to water) | Goal-directed performance and neuronal activity in corticostriatal circuits |
| Furlong (2014) [ | Animal | Male Long-Evans rats | 8/10 | AMPA-receptor and dopamine D1-receptor antagonists | Habitual performance following restricted access to a highly palatable food |
| Gearhardt (2011) [ | Cross-sectional | Young women | 39/0 | Food addiction symptoms (YFAS continuous) | FMRI patterns of neural activation similar to substance dependence (in response to actual and anticipated receipt of chocolate milkshake) |
| Imperatori (2015) [ | Cross-sectional | Adults with overweight or obesity admitted to a medical center for obesity treatment | 14/14 | Food addiction symptoms (I-YFAS continuous and dichotomous); taste of chocolate milkshake | EEG modifications and connectivity |
| Johnson (2010) [ | Animal | Male Wistar rats | 22/9 | Restricted vs. extended access to “cafeteria style” diet (e.g., bacon, sausage, cheesecake, frosting) | Brain stimulation reward threshold; body weight change; caloric intake; type of food consumed (cafeteria vs. chow) |
| Johnson (2010) [ | Animal | Male Wistar rats | Not reported | Restricted vs. extended access to cafeteria style diet; body weight; knockdown of striatal dopamine D2 receptor | Reward hyposensitivity (measured by striatal D2 receptor density); brain stimulation reward threshold; body weight change; caloric intake; type of food consumed (cafeteria vs. chow) |
| Johnson (2010) [ | Animal | Male Wistar rats | Not reported | Restricted vs. extended access to cafeteria style diet followed by intermittent access (30 min) to cafeteria food; environmental stimulus (light) predicting adversity (foot shock) | Brain stimulation reward threshold; body weight change; caloric intake; type of food consumed (cafeteria vs. chow); compulsive-like eating behavior |
| Johnson (2010) [ | Animal | Male Wistar rats | Not reported | Restricted vs. extended access to cafeteria style diet; knockdown of striatal dopamine D2 receptor; environmental stimulus (light) predicting foot shock | Brain stimulation reward threshold; caloric intake; type of food consumed (cafeteria vs. chow); compulsive-like eating behavior |
| Konkolÿ Thege (2015) [ | Longitudinal study | Adults | 4121/0 | Over-involvement (causing significant problems) in one of six excessive behaviors (including eating) | Prevalence, substance use comorbidity, five-year trajectory |
| Le Merrer (2006) [ | Animal | Male mice | 20/10 | Sweetened pellets while hungry vs. while satiated | Behavioral sensitization (assessed by locomotor activity in sweetened-pellet-paired environment) |
| Le Merrer (2006) [ | Animal | Male mice | 9-10/0 | Dopaminergic agonists (SCH23390, sulpiride) | Pellet-induced conditioned activity |
| Le Merrer (2006) [ | Animal | Male mice | 20/0 | Opiate (naltrexone) and AMPA (GYKI 52466) receptor antagonists | Pellet-induced conditioned activity |
| Le Merrer (2006) [ | Animal | Male mice | 20/0 | Cocaine or morphine; pretreatment of GYKI 52466, naltrexone, or SCH23390 | Cross-sensitization (pellet-induced conditioned activity following cocaine or morphine injection) |
| Le Merrer (2006) [ | Animal | Male mice | 7–9/0 | Sweetened-pellet-conditioned environment | Consumption of sweetened pellets; locomotor activity |
| Lenoir (2007) [ | Animal | Young male Wistar rats | 132/0 | Mutually exclusive choice between sweetened water and intravenous cocaine; history of cocaine preference | Preferred substance (saccharin, sugar, or cocaine) |
| Lent (2012) [ | Cross-sectional | Adult bariatric surgery candidates | 97/0 | Addictive personality (Eysenck Personality Questionnaire Addiction Scale) | Maladaptive eating behaviors (Overeating Questionnaire; binge-eating questions from Questionnaire of Eating and Weight Patterns; Eating Attitudes and Behaviors Questionnaire) |
| Mangabeira (2015) [ | Animal | Male Wistar rats | 14/14 | Withdrawal from prolonged sugar consumption | Impulsivity (assessed by differential reinforcement of low rate performance) |
| Markus (2017) [ | Cross-Sectional | Undergraduates | 1495/0 | Food addiction (YFAS dichotomous, continuous} | Depressive symptoms; BMI; YFAS; “problem foods” (high-fat savory, high-fat sweet, low-fat sugary, low-fat savory) |
| Mary Brown (2015) [ | Animal | Male Sprague-Dawley rats | Not reported | Propensity to diet-induced obesity | Addictive-like behavior (i.e., heightened motivation; excessive intake; increased food seeking); synaptic impairments in NAc |
| McGee (2010) [ | Animal | Male Long–Evans rats | 16/8 | Withdrawal from intermittent access to a sweet fat mixture | Motivation (operant performance for sucrose on progressive ratio schedule); craving (lever pressing for palatable food); anxiety (elevated plus maze) |
| Merlo (2009) [ | Cross-sectional | 50/0 children and their parent/guardian | BMI; Food addiction symptoms (Eating Behaviors Questionnaire) | Food- and eating-related attitudes and behaviors | |
| Newman (2013) [ | Animal | Male Sprague-Dawley rats | 10/11 | Bouts of sweetened-fat intake (shortening with 10% sucrose); predator stress; intra-NAc shell infusions of either d-amphetamine or opioid agonist DAMGO; GABA agonist, muscimol | Neuroadaptations in NAc shell GABA systems |
| Pérez-Ortiz (2016) [ | Animal | C57BL/6J male mice | 20/20 | High fat diet followed by 12 h food deprivation | Palatable food seeking; expression of potential addiction biomarkers in the NAc: fumarate hydratase (FH), ATP synthase subunit alpha (ATP5a1) and transketolase (TKT) |
| Pickering (2009) [ | Animal | Male Wistar rats | 12/0 | Sugar content of pellets (50% vs. 95%) | Sugar consumption |
| Pickering (2009) [ | Animal | Male Wistar rats | 9/3 | High-fat high-sugar diet (lard, sucrose) | Caloric intake; body weight change |
| Pickering (2009) [ | Animal | Male Wistar rats | 16/8 | High-fat high-sugar diet (lard, sucrose); vulnerability for weight gain; withdrawal from lard and sucrose diet | Caloric intake; body weight change; motivation for sugar; anxiety-like behavior (open-field test) |
| Schulte (2015) [ | Cross-sectional | Undergraduates | 120/0 | Food items (e.g., chocolate, broccoli) and types (e.g., processed) | Food addiction symptoms (YFAS) |
| Schulte (2015) [ | Cross-sectional | Adults | 384/0 | Food characteristics (e.g., proportions of fats, carbohydrates; level of processing) | Self-reported problematic eating behavior |
| Sharma (2013) [ | Animal | Male mice | 12 (treated + control) | High fat diet (58% kcal from fat: including hydrogenated coconut oil, maltodextrin, sucrose, casein) vs. ingredient-matched low fat diet (10.5% kcal from fat); withdrawal from diet | Motivation for sucrose or high-fat reward; caloric intake; body weight change |
| Sharma (2013) [ | Animal | Male mice | 30 (treated + control) | High fat diet vs. low fat diet (10.5% kcal from fat); withdrawal from diet | Anxiety-like behavior (elevated plus maze); plasma corticosterone |
| Sharma (2013) [ | Animal | Male mice | 48 (treated + control) | High fat diet vs. low fat diet (10.5% kcal from fat); withdrawal from diet | Basal corticosterone; protein levels for tyrosine hydroxylase, corticosterone releasing factor type 1 receptor, BDNF, phospho-CREB and ΔFosB in amygdala, NAc and ventral tegmental area via western immunoblotting |
| Spring (2008) [ | Double-blind within and between subjects cross-over | Women who are overweight or obese | 61/0 | Negative mood; consumption of carbohydrate-rich beverage | Mood; drink preference (carbohydrate-rich vs. macronutrient-balanced) during negative mood state |
| Tuomisto (1999) [ | Case-control | Women | 16/15 | Self-identified “chocolate addiction”; type of exposure to chocolate (look, smell, or taste) | Psychological symptoms (e.g., depression, disinhibition, disordered eating) measured by questionnaires; self-reported reactivity to cues (e.g., anxiety, calmness); salivation, heart rate |
| Tuomisto (1999) [ | Case-control | Women | 16/15 | Self-identified “chocolate addiction”; type of exposure to chocolate (look or smell) | Amount of chocolate consumed; psychological symptoms (e.g., depression, disinhibition, disordered eating) measured by questionnaires; self-reported reactivity to cues (e.g., anxiety, calmness); salivation, heart rate |
| Yakovenko (2011) [ | Animal | Occidental low- and high-saccharin-consuming rats (LoS and HiS, respectively) | 13–15/0 | Line of ingestive phenotype (LoS vs. HiS); periodic access to glucose solution followed by 24 h food withdrawal | Withdrawal symptoms (acoustic startle); glucose consumption |
| Yakovenko (2011) [ | Animal | LoS and HiS rats | 8/0 | Line of ingestive phenotype (LoS vs. HiS); periodic access to glucose solution followed by 24 h food withdrawal; naloxone | Withdrawal symptoms (e.g., startle behavior); glucose consumption |
| Yakovenko (2011) [ | Animal | LoS and HiS rats | 8/0 | Binge-like feeding of cookies and shortening | Cookie, shortening, and ethanol consumption |
Risk of bias assessment of included studies.
| Was a Random or Pseudo Random Sample Used? | Was the Inclusion Criteria Clearly Defined? | Were Confounding Factors Identified and Control Strategies Stated? | Were Outcomes Assessed Using Objective Criteria? | Was There Sufficient Description of the Groups? | Is There a Description of Withdrawals and Drop-Outs? | Are the Methods of Statistical Analysis Described? | Is the Source of Financial Support Described? | Is There a Description of Investigators and Assessors, with Possible Conflicts of Interest? | Quality Score [Y/(N + UC)] | |
|---|---|---|---|---|---|---|---|---|---|---|
| Adams (2015) [ | Y | Y | Y | Y | Y | Y | Y | Y | Y | All Ys |
| Burmeister (2013) [ | N | Y | UC | Y | N/A | Y | Y | N | N | 1 |
| Cambridge (2013) [ | Y | Y | Y | Y | Y | Y | Y | Y | Y | All Ys |
| Colantuoni (2001) [ | Y | Y | Y | Y | Y | Y | Y | Y | N | 8 |
| Cornelis (2016) [ | N | Y | Y | Y | N/A | Y | Y | Y | Y | 7 |
| Daubenmier (2014) [ | Y | Y | Y | Y | UC | Y | Y | Y | N | 3.5 |
| Davis (2011) [ | N | Y | UC | Y | Y | UC | Y | N | N | 0.8 |
| Davis (2013) [ | N | Y | Y | Y | Y | UC | Y | Y | Y | 3.5 |
| Davis (2014) [ | Y | Y | Y | Y | Y | N | Y | N | Y | 3.5 |
| De Ridder (2016) [ | N | Y | Y | Y | Y | UC | Y | N | Y | 2 |
| Duarte (2014) [ | Y | Y | Y | Y | Y | Y | Y | Y | N | 8 |
| Feldstein Ewing (2017) [ | N | Y | Y | Y | N/A | N | Y | Y | Y | 3 |
| Fowler (2014) [ | UC | Y | Y | Y | UC | N | UC | Y | Y | 1.25 |
| Franken (2016) [ | N | Y | Y | Y | Y | Y | Y | N | Y | 3.5 |
| Furlong (2014) [ | Y | Y | Y | Y | Y | Y | Y | Y | Y | All Ys |
| Gearhardt (2011) [ | UC | Y | Y | Y | N | N | Y | Y | Y | 2 |
| Imperatori (2015) [ | UC | Y | Y | Y | Y | UC | Y | N | Y | 2 |
| Johnson (2010) [ | Y | Y | Y | Y | Y | UC | Y | Y | Y | 8 |
| Konkolÿ Thege (2015) [ | N | N | UC | Y | Y | Y | Y | Y | Y | 2 |
| Le Merrer (2006) [ | Y | Y | Y | Y | Y | N | Y | N | N | 2 |
| Lenoir (2007) [ | Y | Y | Y | Y | Y | Y | Y | Y | Y | All Ys |
| Lent (2012) [ | N | N | Y | Y | N/A | Y | Y | Y | Y | 3 |
| Mangabeira (2015) [ | Y | Y | Y | Y | Y | UC | Y | Y | N | 3.5 |
| Markus (2017) [ | N | N | Y | Y | N | UC | Y | Y | Y | 1.25 |
| Mary Brown (2015) [ | Y | Y | Y | Y | Y | UC | Y | Y | Y | 8 |
| McGee (2010) [ | Y | Y | Y | Y | Y | Y | Y | Y | N | 8 |
| Merlo (2009) [ | N | Y | UC | Y | Y | UC | Y | Y | N | 1.25 |
| Newman (2013) [ | Y | Y | Y | Y | Y | UC | Y | Y | Y | 8 |
| Pérez-Ortiz (2016) [ | Y | Y | Y | Y | Y | Y | Y | Y | N | 8 |
| Pickering (2009) [ | N | Y | Y | Y | Y | Y | Y | Y | N | 3.5 |
| Schulte (2015) [ | N | N | Y | Y | N/A | Y | Y | Y | Y | 3 |
| Sharma (2013) [ | Y | Y | Y | Y | Y | UC | Y | Y | Y | 8 |
| Spring (2008) [ | N | Y | Y | N | N/A | Y | Y | Y | N | 1.67 |
| Tuomisto (1999) [ | Y | UC | Y | Y | Y | Y | Y | N | N | 2 |
| Yakovenko (2011) [ | Y | Y | Y | Y | Y | UC | Y | Y | N | 3.5 |
N = No, Y = Yes, UC = Unclear, N/A = Non-Applicable.
Evidence for and against addiction criteria.
| Characteristic | Supporting Evidence | Null/Contrary Evidence |
|---|---|---|
| Brain changes | Animal studies: Adams (2015) [ Colantuoni (2001) [ Duarte (2014) [ Furlong (2014) [ Johnson (2010) [ Johnson (2010) [ Le Merrer (2006) [ Le Merrer (2006) [ Mary Brown (2015) [ Newman (2013) [ Pérez-Ortiz (2016) [ Sharma (2013) [ Cambridge (2013) [ Daubenmier (2014) [ Davis (2013) [ Davis (2014) [ De Ridder (2016) [ Feldstein Ewing (2017) [ Franken (2016) [ Gearhardt (2011) [ Imperatori (2015) [ | Adams (2015) [ |
| Preoccupation | Human studies: Merlo (2009) [ Tuomisto (1999) [ Tuomisto (1999) [ | N/A |
| Impaired control | Animal studies: Furlong (2014) [ Lenoir (2007) [ Mary Brown (2015) [ Burmeister (2013) [ Davis (2011) [ Davis (2013) [ Davis (2014) [ Feldstein Ewing (2017) [ Lent (2012) [ Merlo (2009) [ Tuomisto (1999) [ Tuomisto (1999) [ | N/A |
| Social impairment | Animal studies: Adams (2015) [ Lent (2012) [ | N/A |
| Risky use | Animal studies: Johnson (2010) [ | N/A |
| Tolerance/Withdrawal | Animal studies: Johnson (2010) [ Mangabeira (2015) [ Pickering (2009) [ Sharma (2013) [ De Ridder (2016) [ Lent (2012) [ Markus (2017) [ Spring (2008) [ | Yakovenko (2011) [ |
| Chronicity | Animal studies: McGee (2010) [ Pickering (2009) [ | Konkolÿ Thege (2015) [ |
| Relapse | Animal studies: Pickering (2009) [ Sharma (2013) [ | N/A |
| Overall | Human studies: Tuomisto (1999) [ Tuomisto (1999) [ Schulte (2015) [ Schulte (2015) [ | N/A |